Spinal Cord Injury, ChronicCombinatorialNCT07135583
Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury
A study testing Active Comparator: Single Intervention 1, Active Comparator: Single Intervention 2 and Respiratory Resistance Exercise in people with Spinal Cord Injury, Chronic and Spinal Cord Injury Cervical, run by Thomas Jefferson University at 1 site in United States.
Trial summary
Spinal cord injuries (SCI) can seriously affect a person's ability to breathe. This happens because the injury can damage the nerves that control the muscles used for breathing. As a result, people with SCI often face breathing problems, a higher risk of lung infections, and even early death. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Spinal Cord Injury, Chronic, Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic
- What is being tested?
- Active Comparator: Single Intervention 1, Active Comparator: Single Intervention 2 and Respiratory Resistance Exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- 18 Sep 2025to 15 Aug 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- adults 18 to 70 years of age (the latter to reduce likelihood of cardiovascular disease);
- chronic SCI for ≥ 1 year at or below C-3 to T-8
- incomplete SCI based on classification of incomplete-B, C or D
- medically stable with clearance from physician
- SCI due to non-progressive etiology
- >20% impairment in maximal inspiratory or expiratory pressure generation
Who cannot join
- Individuals will be excluded due to (1) current diagnosis of an additional neurologic condition (eg. multiple sclerosis or stroke) (2) loss of diaphragm EMG activity on forced respiratory tests; (3) severe illness or infection (4) non-healing decubitus ulcers (5) untreated bladder or urinary infections (6) cardiovascular disease (7) lung disease (8) active heterotopic ossification (9) uncontrolled hypertension; (10) severe neuropathic pain; (11) pregnancy (5) severe recurrent and uncontrolled autonomic dysreflexia (6) history of seizure disorder.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Thomas Jefferson University Center City Campus
Philadelphia, Pennsylvania, 19107
Jayakrishnan, 3528715888, jayakrishnan.nair@jefferson.edu
About this study
Official title: Non-Invasive Interventions and Biomarker Identification for Respiratory Recovery in Chronic Spinal Cord Injury
Spinal cord injuries (SCI) can seriously affect a person's ability to breathe. This happens because the injury can damage the nerves that control the muscles used for breathing. As a result, people with SCI often face breathing problems, a higher risk of lung infections, and even early death. While breathing exercises can help strengthen these muscles, they often aren't intense enough to make a big difference, especially in people with long-term injuries.
This research project is exploring a new way to improve breathing in people with chronic SCI. The goal is to "wake up" the remaining nerve pathways that still connect the brain and spinal cord to the breathing muscles. By doing this, the investigators hope to make breathing exercises more effective and improve overall respiratory health.
Read more
The investigators are testing a combination of two non-invasive (non-surgical) techniques:
Transcutaneous Spinal Cord Stimulation (tSCS): This uses small electrical pulses delivered through the skin to stimulate the spinal cord and help activate the muscles used for breathing.
Hypercapnic-Hypoxia Protocol (HiCO₂-AIH): This involves breathing air with lower oxygen and higher carbon dioxide for short periods. This naturally increases the brain's drive to breathe and may help strengthen the breathing muscles.
The investigators believe that using these two techniques together will "prime" the nervous system, making it more responsive to breathing exercises. This could lead to better outcomes for people with SCI.
In addition to testing this treatment, the investigators are also collecting saliva and blood samples to look for biomarkers-biological clues that might help predict who will benefit most from this therapy. These include genetic markers and signs of nerve damage in the blood.
Who Can Participate
The investigators are looking for adults aged 18 to 70 who:
Have had a spinal cord injury for at least one year. Have an injury between the neck and upper back (from C3 to T8). Have an incomplete injury (some nerve function remains). Are medically stable and cleared by a doctor. Have at least a 20% reduction in breathing strength. What Participants Will Do
Each participant will complete four rounds of treatment. Each round includes four days in a row of therapy, followed by a three-week break before the next round.
Each daily session lasts about two hours and includes:
Breathing special air mixtures (low oxygen and high carbon dioxide) for short periods, followed by normal air.
A short break. Then, spinal cord stimulation combined with breathing exercises that use resistance (like breathing through a straw).
What the Investigators Will Measure
The investigators will track:
Breathing ability using lung function tests and pressure measurements. Nerve activity using brain and spinal cord stimulation to see how well the diaphragm (the main breathing muscle) responds.
Safety by monitoring oxygen levels, heart rate, blood pressure, and breathing responses during each session.
Biological Samples
Participants will provide:
A one-time saliva sample for genetic testing. A one-time blood sample to look for markers of nerve injury. Why This Matters
This study could lead to new, non-invasive treatments that improve breathing and quality of life for people living with spinal cord injuries. By identifying who is most likely to benefit from this therapy, the investigators can also move toward more personalized and effective care in the future.
Read the detailed description
The overall objectives of this study are:
To determine whether combining hypercapnic-hypoxia protocol (HiCO₂-AIH) and transcutaneous spinal cord stimulation (tSCS) can enhance the effects of respiratory resistance training in individuals with chronic spinal cord injury (SCI).
To explore whether genetic and blood-based biomarkers can help predict how individuals respond to this combined intervention.
We will test these objectives in adults with chronic SCI using a Williams cross-over design. The study will include 16 participants (with statistical power >0.8 and α=0.05), accounting for a 20% dropout rate, for a total enrollment of 20 participants.
Specific Aims
Aim 1:
To determine whether four consecutive days of combined HiCO₂-AIH and tSCS will improve the effectiveness of respiratory resistance training compared to either intervention alone.
Outcomes (measured from PRE to 1 day POST intervention):
Primary Outcome: Change in mouth occlusion pressure at 0.1 seconds (P0.1). Secondary Outcomes: Maximal inspiratory and expiratory pressure generation, forced vital capacity (FVC), neurophysiological measures of cortico-spinal drive (amplitude of transcranial magnetic stimulation [TMS]) and local spinal excitability (amplitude of cervical magnetic stimulation [CMS]) in the diaphragm.
Safety Outcomes: Continuous monitoring of respiratory parameters (end tidal oxygen [O₂] and carbon dioxide [CO₂] concentration, oxygen saturation [SpO₂]) and cardiovascular parameters (blood pressure [BP], heart rate [HR], and electrocardiogram [ECG]) during each session.
Aim 2:
To identify predictive factors for treatment response to the combined HiCO₂-AIH and tSCS intervention using:
- Genetic polymorphisms related to intermittent hypoxia signaling pathways.
- Molecular markers of neurotrauma and inflammation found in blood extracellular vesicles (EVs).
Outcomes:
Regression analyses will be conducted to examine the relationship between treatment outcomes and:
Specific genetic single nucleotide polymorphisms (SNPs). Blood-based molecular markers of neurotrauma and inflammation.
- Conditions
- Spinal Cord Injury, Chronic, Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic, Incomplete Spinal Cord Injury
- Being tested
- Active Comparator: Single Intervention 1, Active Comparator: Single Intervention 2, Respiratory Resistance Exercise
- Keywords
- "Spinal Cord Stimulation" [MeSH], acute intermittant hypoxia, respiratory resistance training, Genetic Biomarker, Blood biomarker
- Medical subject headings
- Spinal Cord Injuries, Bronchiolitis Obliterans Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Active Comparator: Single Intervention 1Other
Acute intermittent hypercapnic-hypoxia (15 episodes of 1.5 minute O2= 9%, CO2=4% and balance N2, interspaced with 1.5 min room air
Active Comparator: Single Intervention 2Other
An open-loop continuous tSCS stimulation [30 min duration, low frequency (30 Hz), tolerable intensity (~10-15 mA), 400 µsec pulse width, biphasic symmetric waveform] will be delivered using 2 channels: Channel 1- C4-C5 spine; Channel 2- T4 spine; returning electrodes at ASIS.
Respiratory Resistance ExerciseBehavioural
Also called Respiratory Strength Training, Inspiratory resistance training, Expiratory resistance training
Respiratory strength training will be conducted using a standard, spring-loaded threshold device while the participant is receiving either tSCS or Sham tSCS. Participants will complete one warm-up set at a pressure threshold approximately 40% of their pre-test outcomes (obtained on day 1 of the corresponding intervention block) for maximal inspiratory and expiratory pressure generation. Following the warm-up, participants will train at a pressure threshold approximately 70% of their pre-test outcomes and will complete three sets of 6-12 repetitions for both inspiratory and expiratory strength training. A training breath will consist of a ~1-2-second sustained effort through the device, separated by 5-10 seconds of quiet breathing. The order of the three sets each of inspiratory or expiratory training will alternate for each of the five daily sessions; the order on day 1 of training will be randomly determined.
| Study group | Role | What they receive |
|---|---|---|
| Combined Intervention | Experimental | Experimental Combination of HiCO2-AIH+ tSCS paired respiratory exercise Receives: Other: Active Comparator: Single Intervention 1; Other: Active Comparator: Single Intervention 2; Behavioral: Respiratory Resistance Exercise |
| Single Intervention 1 | Active comparator | Combination of HiCO2-AIH+ Sham stimulation paired respiratory exercise Receives: Other: Active Comparator: Single Intervention 1; Behavioral: Respiratory Resistance Exercise |
| Single Intervention 2 | Active comparator | Combination of Sham Exposure + tSCS paired respiratory exercise Receives: Other: Active Comparator: Single Intervention 2; Behavioral: Respiratory Resistance Exercise |
| Sham Intervention | Placebo comparator | Combination of Sham Exposure + Sham Stimulation paired respiratory exercise Receives: Behavioral: Respiratory Resistance Exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
change in mouth occlusion pressure at 0.1 secs (P0.1)
It measures the pressure generated at the mouth in the first 0.1 second of inspiration when the airway is unexpectedly occluded at the end of expiration. The negative pressure generation in 0.1 seconds reflects respiratory motor drive without time for modification by sensory systems such as lung stretch or visual input. The inspiratory valve will be occluded prior to the onset of inspiration, without participant awareness, and maintained until the subsequent inspiratory effort. Negative pressure generation will be recorded using a pressure transducer connected to a non-rebreathable mask. All respiratory assessments will be performed in accordance with standard testing guidelines. Measurement indices of ventilation will be obtained using a mouthpiece attached to the pneumotach and nasal clips. The mouth pressure from the pneumotach will be converted to a digital signal using Powerlab C.
Measured: Pre- Baseline (Day 1), Post 1(30 minute post day 4 intervention) and Post 2 ( 24 hours post day 4 intervention)
Secondary outcomes (4)
Maximum Inspiratory (MIP) & Expiratory (MEP) Pressure
Inspiratory pressure generation is indicative of inspiratory strength and is associated with pulmonary health and infection risk. Expiratory pressure generation reflects expiratory respiratory strength and is associated with airway clearance and cough. Inspiratory and expiratory pressure generation improve following weeks of respiratory strength training and after single-day sessions of AIH. Measurements will be obtained using a mouthpiece attached to the pneumotach to measure indices of ventilation, along with the use of nasal clips. To obtain MIP, participants will exhale to residual volume and attempt a maximal inspiration for at least 2 seconds with the inspired line occluded. MEP will be measured with forced expiration against an occluded expired line after the participant inhales to near total lung capacity.
Measured: Pre- Baseline (Day 1), Post 1(30 minute post day 4 intervention) and Post 2 ( 24 hours post day 4 intervention)
Sniff nasal inspiratory pressure (SNIP)
Sniff nasal inspiratory pressure (SNIP) is the measurement of esophageal pressure during maximal sniffs and can be useful in assessing inspiratory muscle strength. To obtain SNIP, the pressure measurement will be obtained through an occluded nostril using a nasal probe, as the participant performs a sniff through the contralateral nostril.
Measured: Pre- Baseline (Day 1), Post 1(30 minute post day 4 intervention) and Post 2 ( 24 hours post day 4 intervention)
Transcranial Magnetic Stimulation (TMS) evoked Diaphragm Motor Evoked Potentials
Subjects will be seated comfortably, fully supported, with their neck slightly flexed. Transcranial magnetic stimulation is performed using a standard technique. The vertex of the skull is identified by the intersection between nasion to inion and tragus to tragus. The region of the cortex responsible for diaphragm motor activation is located approximately 3 cm lateral and 2 cm anterior to the vertex. Single-pulse stimuli are delivered using a handheld double cone coil powered by a magnetic stimulator. The coil is held over the left hemisphere of the brain with current flowing in the anteroposterior direction. The coil is then moved slightly from the pre-determined site and rotated in 45° increments until the largest motor evoked potential (MEP) is observed. This location is marked on a tight-fitting TMS cap placed over the subject's head to ensure accurate coil positioning in future stimulations.
Measured: Pre- Baseline (Day 1), Post 1(30 minute post day 4 intervention) and Post 2 ( 24 hours post day 4 intervention)
Cervical Magnetic Stimulation (CMS) Diaphragm motor evoked potentials
Single-pulse stimuli will be delivered using a handheld circular coil placed over the cervical spine (C7). Recruitment curves are plotted by gradually increasing the intensity of stimulus from 40% to 100% of the maximal stimulator output in 5% increments. Approximately 15 stimulations will be performed at each intensity, separated by 30 seconds. If the subject wishes to take an extended break between stimulations, they may do so until ready to continue.
As with all procedures, participants will be closely monitored for any discomfort. During these stimulation procedures, subjects will be closely monitored for discomfort and are encouraged to inform the experimenter if they wish to pause testing, take a break, or discontinue stimulations.
Measured: Pre- Baseline (Day 1), Post 1(30 minute post day 4 intervention) and Post 2 ( 24 hours post day 4 intervention)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Aug 2025
- Study start18 Sep 2025
- Primary completion15 Aug 2027 (estimated)
- Study completion15 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Spinal Cord Injury, ChronicStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- A Single-blind, placebo-controlled, randomized order, William Latin cross-over experimental design
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Thomas Jefferson University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jayakrishnan Nair, Thomas Jefferson University
- Investigators
- Jay Nair, PT, PhD, Principal investigator, Thomas Jefferson University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07135583
- Sponsor's protocol ID
- IRBID-2023-1796
- Other IDs
- 1349389
- Acronym
- Combinatorial
- Status last verified
- Oct 2025
- First submitted
- 14 Aug 2025
- Last updated
- 5 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All digital research material included but not limited to images, spreadsheets, protocols, and analysis scripts will be archived and made available via Open Data Commons for Spinal Cord Injury (ODC-SCI) or similar site.